Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 15 | 2024 | 734 | 3.620 |
Why?
|
| Desensitization, Immunologic | 18 | 2021 | 545 | 3.580 |
Why?
|
| Allergens | 17 | 2024 | 1435 | 2.000 |
Why?
|
| Peanut Hypersensitivity | 9 | 2021 | 217 | 1.880 |
Why?
|
| Antibodies, Anti-Idiotypic | 5 | 2018 | 340 | 1.300 |
Why?
|
| Biological Therapy | 2 | 2020 | 140 | 1.190 |
Why?
|
| Urticaria | 2 | 2019 | 151 | 1.130 |
Why?
|
| Anti-Allergic Agents | 5 | 2024 | 153 | 1.130 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2024 | 346 | 0.760 |
Why?
|
| Common Variable Immunodeficiency | 7 | 2018 | 99 | 0.760 |
Why?
|
| gamma-Globulins | 2 | 2011 | 119 | 0.760 |
Why?
|
| Immunoglobulin E | 6 | 2021 | 1479 | 0.700 |
Why?
|
| Bee Venoms | 1 | 2018 | 14 | 0.620 |
Why?
|
| Vaccines, DNA | 1 | 2020 | 279 | 0.610 |
Why?
|
| Models, Immunological | 1 | 2020 | 517 | 0.610 |
Why?
|
| T-Lymphocytes, Regulatory | 7 | 2020 | 3111 | 0.590 |
Why?
|
| Insect Bites and Stings | 1 | 2018 | 71 | 0.590 |
Why?
|
| Anaphylaxis | 3 | 2018 | 738 | 0.590 |
Why?
|
| Immunoglobulins, Intravenous | 3 | 2013 | 667 | 0.580 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 5 | 2015 | 55 | 0.580 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2018 | 101 | 0.560 |
Why?
|
| IgA Deficiency | 4 | 2013 | 39 | 0.510 |
Why?
|
| Agammaglobulinemia | 2 | 2017 | 173 | 0.500 |
Why?
|
| Immunoglobulin A | 3 | 2020 | 992 | 0.490 |
Why?
|
| Drug Hypersensitivity | 3 | 2020 | 903 | 0.490 |
Why?
|
| Cold Temperature | 1 | 2018 | 793 | 0.470 |
Why?
|
| Biological Products | 2 | 2021 | 947 | 0.460 |
Why?
|
| Feces | 2 | 2020 | 1503 | 0.440 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2012 | 56 | 0.390 |
Why?
|
| Th2 Cells | 4 | 2019 | 1074 | 0.360 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2020 | 151 | 0.360 |
Why?
|
| Gelatin | 1 | 2012 | 227 | 0.340 |
Why?
|
| Immunoglobulin G | 7 | 2021 | 4555 | 0.320 |
Why?
|
| Plant Proteins | 3 | 2021 | 374 | 0.290 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2011 | 547 | 0.290 |
Why?
|
| Administration, Oral | 8 | 2020 | 4016 | 0.280 |
Why?
|
| Immunotherapy | 2 | 2019 | 4746 | 0.250 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 1169 | 0.250 |
Why?
|
| Food | 3 | 2019 | 764 | 0.240 |
Why?
|
| Immunity, Mucosal | 2 | 2020 | 498 | 0.230 |
Why?
|
| Child, Preschool | 12 | 2024 | 42510 | 0.210 |
Why?
|
| Child | 19 | 2024 | 80568 | 0.210 |
Why?
|
| Asthma | 2 | 2019 | 6268 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9239 | 0.190 |
Why?
|
| B-Lymphocytes | 6 | 2021 | 4782 | 0.190 |
Why?
|
| Antigens, Plant | 2 | 2021 | 103 | 0.190 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2010 | 1881 | 0.190 |
Why?
|
| Eczema | 1 | 2024 | 244 | 0.190 |
Why?
|
| Th1 Cells | 2 | 2019 | 1040 | 0.180 |
Why?
|
| Epitope Mapping | 1 | 2021 | 300 | 0.180 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2018 | 197 | 0.170 |
Why?
|
| Humans | 45 | 2024 | 765926 | 0.160 |
Why?
|
| Th1-Th2 Balance | 1 | 2019 | 38 | 0.160 |
Why?
|
| Lymphocyte Activation | 4 | 2018 | 5500 | 0.150 |
Why?
|
| Bees | 1 | 2018 | 48 | 0.150 |
Why?
|
| Receptors, Cytokine | 1 | 2019 | 257 | 0.150 |
Why?
|
| Diet Therapy | 1 | 2019 | 149 | 0.150 |
Why?
|
| Pollen | 1 | 2018 | 79 | 0.140 |
Why?
|
| Drug Dosage Calculations | 1 | 2018 | 116 | 0.140 |
Why?
|
| Adolescent | 14 | 2020 | 88811 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 637 | 0.130 |
Why?
|
| Accidents | 1 | 2017 | 164 | 0.130 |
Why?
|
| Injections, Subcutaneous | 1 | 2018 | 682 | 0.130 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2015 | 19 | 0.120 |
Why?
|
| Epitopes | 1 | 2021 | 2523 | 0.120 |
Why?
|
| Animals | 14 | 2024 | 168735 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 582 | 0.120 |
Why?
|
| Epinephrine | 1 | 2018 | 782 | 0.120 |
Why?
|
| Autoimmunity | 2 | 2020 | 1354 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 871 | 0.110 |
Why?
|
| Skin Tests | 2 | 2016 | 630 | 0.110 |
Why?
|
| Quality of Life | 3 | 2021 | 13463 | 0.100 |
Why?
|
| Probiotics | 1 | 2016 | 387 | 0.100 |
Why?
|
| Vitreoretinopathy, Proliferative | 1 | 2013 | 75 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1084 | 0.100 |
Why?
|
| Spinal Cord Regeneration | 1 | 2012 | 10 | 0.100 |
Why?
|
| Seasons | 1 | 2018 | 1522 | 0.100 |
Why?
|
| Immune Tolerance | 2 | 2017 | 2324 | 0.090 |
Why?
|
| Hypersensitivity | 1 | 2020 | 1167 | 0.090 |
Why?
|
| Receptors, IgG | 1 | 2014 | 559 | 0.090 |
Why?
|
| Metabolomics | 1 | 2019 | 1667 | 0.090 |
Why?
|
| Female | 19 | 2024 | 396141 | 0.080 |
Why?
|
| Combined Modality Therapy | 3 | 2018 | 8522 | 0.080 |
Why?
|
| Thrombin | 1 | 2012 | 601 | 0.080 |
Why?
|
| Male | 18 | 2019 | 363815 | 0.080 |
Why?
|
| Cytokines | 2 | 2019 | 7417 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 2227 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2814 | 0.060 |
Why?
|
| Mast Cells | 3 | 2020 | 1404 | 0.060 |
Why?
|
| Ovalbumin | 2 | 2019 | 674 | 0.060 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2006 | 289 | 0.060 |
Why?
|
| Double-Blind Method | 4 | 2020 | 12417 | 0.060 |
Why?
|
| Risk Factors | 3 | 2018 | 74850 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2018 | 65194 | 0.060 |
Why?
|
| Diabetic Retinopathy | 1 | 2013 | 1294 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3801 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 2046 | 0.050 |
Why?
|
| Gene Dosage | 2 | 2020 | 1213 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2018 | 81537 | 0.050 |
Why?
|
| Infant | 4 | 2020 | 36426 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 588 | 0.050 |
Why?
|
| Adult | 11 | 2024 | 223088 | 0.050 |
Why?
|
| Seed Storage Proteins | 1 | 2021 | 15 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2015 | 2589 | 0.050 |
Why?
|
| 2S Albumins, Plant | 1 | 2021 | 37 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13614 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 1852 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15878 | 0.040 |
Why?
|
| Peptide Library | 1 | 2021 | 351 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 8037 | 0.040 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2001 | 147 | 0.040 |
Why?
|
| Immunologic Memory | 2 | 2018 | 1374 | 0.040 |
Why?
|
| Mice | 5 | 2020 | 81782 | 0.040 |
Why?
|
| Bacteroides | 1 | 2019 | 165 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2018 | 355 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2018 | 26380 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2021 | 22228 | 0.040 |
Why?
|
| Cattle | 1 | 2024 | 3801 | 0.040 |
Why?
|
| Young Adult | 7 | 2020 | 59857 | 0.040 |
Why?
|
| Receptors, AMPA | 1 | 1999 | 335 | 0.040 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2018 | 240 | 0.030 |
Why?
|
| Ceramides | 1 | 1998 | 201 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2018 | 705 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 40097 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2021 | 7847 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4249 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 938 | 0.030 |
Why?
|
| Hemizygote | 1 | 2015 | 27 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2015 | 196 | 0.030 |
Why?
|
| Consensus | 1 | 2024 | 3202 | 0.030 |
Why?
|
| Age Factors | 2 | 2024 | 18382 | 0.030 |
Why?
|
| Immunization | 1 | 2018 | 1218 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2001 | 1172 | 0.030 |
Why?
|
| Prevalence | 1 | 2010 | 15828 | 0.030 |
Why?
|
| CpG Islands | 1 | 2018 | 1207 | 0.030 |
Why?
|
| Status Epilepticus | 1 | 1999 | 459 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 1476 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2019 | 8724 | 0.030 |
Why?
|
| B-Cell Activating Factor | 1 | 2013 | 115 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1865 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2015 | 334 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2013 | 190 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 18074 | 0.030 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2017 | 386 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2015 | 388 | 0.030 |
Why?
|
| Population Groups | 1 | 2013 | 209 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 1005 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2013 | 169 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9541 | 0.020 |
Why?
|
| Basophils | 1 | 2014 | 392 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 340 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2015 | 602 | 0.020 |
Why?
|
| Aged | 3 | 2019 | 171163 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2015 | 1149 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2015 | 1392 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10426 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6209 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2019 | 23597 | 0.020 |
Why?
|
| Vitrectomy | 1 | 2013 | 389 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 1204 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2492 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3661 | 0.020 |
Why?
|
| Middle Aged | 5 | 2018 | 223016 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2013 | 975 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1998 | 2945 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8279 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 1996 | 0.020 |
Why?
|
| Mutation | 2 | 2013 | 30192 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7599 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 2796 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4405 | 0.020 |
Why?
|
| Phenotype | 2 | 2018 | 16714 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3542 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2013 | 2114 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3816 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2018 | 4424 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11639 | 0.010 |
Why?
|
| Apoptosis | 1 | 1998 | 9505 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2005 | 853 | 0.010 |
Why?
|
| Risk | 1 | 2013 | 9599 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22327 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 2001 | 386 | 0.010 |
Why?
|
| Splenectomy | 1 | 2001 | 389 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 3623 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 59496 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2001 | 777 | 0.010 |
Why?
|
| Mutagenicity Tests | 1 | 1998 | 46 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1999 | 204 | 0.010 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1999 | 141 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 20133 | 0.010 |
Why?
|
| Ligands | 1 | 2005 | 3272 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1998 | 304 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2013 | 18962 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1998 | 364 | 0.010 |
Why?
|
| Maze Learning | 1 | 1999 | 482 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11895 | 0.010 |
Why?
|
| Gamma Rays | 1 | 1998 | 324 | 0.010 |
Why?
|
| Quinoxalines | 1 | 1999 | 296 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2001 | 1835 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1999 | 451 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 1 | 2001 | 574 | 0.010 |
Why?
|
| United States | 1 | 2024 | 72909 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9600 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1607 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1999 | 952 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2001 | 2653 | 0.010 |
Why?
|
| Syndrome | 1 | 2001 | 3271 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2007 | 3594 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 13026 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 27179 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2001 | 2155 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 6306 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15802 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6101 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4213 | 0.000 |
Why?
|
| Cell Line | 1 | 1998 | 15540 | 0.000 |
Why?
|
| Rats | 1 | 1999 | 23708 | 0.000 |
Why?
|
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_